Category: T2 Biosystems Inc.Syndicate content

T2 Biosystems jumps on FDA nod for sepsis tests

September 24, 2014 by Alex Soule

Shares of T2 Biosystems jump nearly 10% after the FDA approves its MR-based tests designed to detect sepsis in a matter of hours rather than days.

T2 Biosystems jumps on FDA nod for sepsis tests

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

T2 Biosystems IPO raises $57M for MRI-based diagnostics

August 7, 2014 by Arezu Sarvestani

Diagnostic devices maker T2 Biosystems raises $57 million in an initial public offering after pricing shares below range at $11 apiece.

T2 Biosystems IPO raises $57M for MRI-based diagnostics

Massachusetts-based (NSDQ:TTOO) fell below target with its initial public offering today, raising $57 million in support of its MRI-based diagnostic systems.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

T2 Biosystems boosts IPO cap to $78.2M

July 30, 2014 by Arezu Sarvestani

MRI diagnostics maker T2 Biosystems releases details on its initial public offering, hoping to raise as much as $78.2 million at $17 per share.

T2 Biosystems boosts IPO to $72.8M

Massachusetts-based  raised its hopes for its upcoming initial public offering, raising its maximum aggregate take to $78.2 million if shares sell at $17 apiece.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

T2 Biosystems prepares to go public in an offering that could garner $69 million | Medtech Wall Street news for the week of July 7, 2014

July 10, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: T2 Biosystems prepares $69M IPO for MRI-based diagnostics; Philips Healthcare retools, CEO DiSanzo is out; iRadimed sets terms for $10M IPO

T2 Biosystems prepares $69M IPO for MRI-based diagnostics

July 2, 2014 by Arezu Sarvestani

T2 Biosystems prepares to go IPO

T2 Biosystems prepares $69M IPO for MRI-based diagnostics

July 2, 2014 by Arezu Sarvestani

Massachusetts-based T2 Biosystems registers for an initial public offering worth up to $69 million in support of its novel magnetic resonance imaging-based diagnostic systems.

T2 Biosystems prepares to go IPO

Diagnostics-maker   is preparing to go public in an offering that could garner as much as $69 million, according to SEC filings.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp